A detailed history of Los Angeles Capital Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 90,567 shares of UTHR stock, worth $32.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
90,567
Previous 99,328 8.82%
Holding current value
$32.6 Million
Previous $31.6 Million 2.57%
% of portfolio
0.13%
Previous 0.11%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$311.04 - $363.55 $2.73 Million - $3.19 Million
-8,761 Reduced 8.82%
90,567 $32.5 Million
Q2 2024

Aug 05, 2024

BUY
$228.26 - $319.04 $2.39 Million - $3.34 Million
10,476 Added 11.79%
99,328 $31.6 Million
Q1 2024

Apr 05, 2024

BUY
$210.76 - $249.51 $3.26 Million - $3.85 Million
15,447 Added 21.04%
88,852 $20.4 Million
Q4 2023

Feb 06, 2024

BUY
$214.88 - $256.94 $4.76 Million - $5.69 Million
22,155 Added 43.23%
73,405 $16.1 Million
Q3 2023

Nov 06, 2023

BUY
$211.82 - $248.24 $9.49 Million - $11.1 Million
44,820 Added 697.05%
51,250 $11.6 Million
Q2 2023

Aug 03, 2023

SELL
$205.19 - $232.99 $20.4 Million - $23.2 Million
-99,413 Reduced 93.92%
6,430 $1.42 Million
Q1 2023

May 04, 2023

BUY
$212.99 - $276.17 $763,995 - $990,621
3,587 Added 3.51%
105,843 $23.7 Million
Q4 2022

Feb 06, 2023

BUY
$205.95 - $280.43 $11 Million - $15 Million
53,444 Added 109.49%
102,256 $28.4 Million
Q3 2022

Nov 02, 2022

BUY
$203.3 - $244.17 $9.92 Million - $11.9 Million
48,812 New
48,812 $10.2 Million
Q2 2021

Aug 05, 2021

SELL
$170.47 - $211.93 $363,782 - $452,258
-2,134 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$153.94 - $174.85 $945,037 - $1.07 Million
-6,139 Reduced 74.21%
2,134 $356,000
Q4 2020

Feb 04, 2021

BUY
$101.87 - $151.79 $12,733 - $18,973
125 Added 1.53%
8,273 $1.26 Million
Q3 2020

Nov 02, 2020

SELL
$99.9 - $121.13 $79,920 - $96,904
-800 Reduced 8.94%
8,148 $823,000
Q2 2020

Aug 05, 2020

BUY
$92.74 - $125.82 $578,697 - $785,116
6,240 Added 230.43%
8,948 $1.08 Million
Q1 2020

May 04, 2020

BUY
$79.39 - $115.35 $214,988 - $312,367
2,708 New
2,708 $257,000
Q2 2019

Jul 29, 2019

SELL
$76.06 - $120.81 $2.11 Million - $3.35 Million
-27,702 Closed
0 $0
Q1 2019

Apr 25, 2019

SELL
$107.15 - $126.84 $185,690 - $219,813
-1,733 Reduced 5.89%
27,702 $3.25 Million
Q3 2018

Nov 05, 2018

SELL
$113.81 - $129.46 $705,394 - $802,393
-6,198 Reduced 17.39%
29,435 $3.76 Million
Q2 2018

Jul 31, 2018

SELL
$101.14 - $118.31 $11.2 Million - $13.1 Million
-110,710 Reduced 75.65%
35,633 $4.03 Million
Q1 2018

Apr 27, 2018

SELL
$107.21 - $151.94 $4.93 Million - $6.98 Million
-45,965 Reduced 23.9%
146,343 $16.4 Million
Q4 2017

Feb 05, 2018

BUY
$118.58 - $151.28 $18.4 Million - $23.5 Million
155,520 Added 422.75%
192,308 $28.5 Million
Q3 2017

Nov 06, 2017

SELL
$114.6 - $136.81 $9.44 Million - $11.3 Million
-82,355 Reduced 69.12%
36,788 $4.31 Million
Q2 2017

Aug 09, 2017

BUY
N/A
119,143
119,143 $15.5 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.